REFRACTORY EWING SARCOMA
Clinical trials for REFRACTORY EWING SARCOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY EWING SARCOMA trials appear
Sign up with your email to follow new studies for REFRACTORY EWING SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids battling tough bone cancer
Disease control Recruiting nowThis study is testing a drug called lurbinectedin in children and young adults whose Ewing sarcoma has come back or hasn't responded to other treatments. The first part aims to find a safe dose, and the second part will see how well the drug works to control the cancer. About 60 …
Matched conditions: REFRACTORY EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called tegavivint in children, teens, and young adults whose solid tumors or lymphomas have come back or haven't responded to other treatments. The main goals are to find the safest dose, understand the side effects, and see if the drug can help s…
Matched conditions: REFRACTORY EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New hope for kids with tough cancers: trial tests Double-Team drug strategy
Disease control Recruiting nowThis study is testing two different drug combinations to find safe doses and see if they can help control cancer in children and young adults whose solid tumors have come back or haven't responded to treatment. In the first part, participants will be assigned to receive either On…
Matched conditions: REFRACTORY EWING SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC